Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

CHARCO CAPS - Health Canada Drug Approval Details

Approvals/Health Canada/CHARCO CAPS

Authorized

STANDARD

CHARCO CAPS

dse healthcare solutions llc🇨🇦 Health Canada

Approval Date: Jul 4, 2025
Approval ID: a22205b2f1d55d66
Company: dse healthcare solutions llc
Type: Standard

Approval Details

Approval Id: a22205b2f1d55d66
Drug Approval Canada Name: CHARCO CAPS
Product Name: CHARCO CAPS
Status: Marketed
Status Date: 2016-01-15
Original Market Date: 2016-01-15
Din: 02423715
Drug Class: Human
Dosage Form: Capsule
Route Of Administration: Oral
Schedule: OTC
Ahfs: 56:04.00
Atc Original: A07BA01 MEDICINAL CHARCOAL
Atc Name: a 07 ba 01
Aig Number: 0106680015
Company Name: dse healthcare solutions llc
Company Address: Po Box 6321, Edison, New Jersey, United States, 08818

Active Ingredients

CHARCOAL ACTIVATED

260 MG

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

a22205b2f1d55d66

Type

Standard

Back to Health Canada Approvals